SYNbiotics Easing Renal failure by improving Gut microbiologY (SYNERGY): a protocol of placebo-controlled randomised cross-over trial

BACKGROUND: Emerging evidence suggests modulating the microbiota in the large bowel of patients with chronic kidney disease (CKD) through pre- and/probiotic supplementation may inhibit the development of key nephrovascular toxins. To date, quality intervention trials investigating this novel treatme...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Rossi, Megan, Johnson, David W, Morrison, Mark, Pascoe, Elaine, Coombes, Jeff S, Forbes, Josephine M, McWhinney, Brett C, Ungerer, Jacobus PJ, Dimeski, Goce, Campbell, Katrina L
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2014
Matèries:
Study Protocol
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4094543/
https://ncbi.nlm.nih.gov/pubmed/24996842
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2369-15-106
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars